BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32187687)

  • 1. No evidence of transfusion transmitted sporadic Creutzfeldt-Jakob disease: results from a bi-national cohort study.
    Holmqvist J; Wikman A; Pedersen OBV; Nielsen KR; Rostgaard K; Hjalgrim H; Edgren G
    Transfusion; 2020 Apr; 60(4):694-697. PubMed ID: 32187687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
    Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
    Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.
    Crowder LA; Schonberger LB; Dodd RY; Steele WR
    Transfusion; 2017 Aug; 57(8):1875-1878. PubMed ID: 28444687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study.
    Crowder LA; Dodd RY; Schonberger LB
    Transfusion; 2024 Jun; 64(6):980-985. PubMed ID: 38650381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
    Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant CJD and blood transfusion: are there additional cases?
    Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
    Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.
    Checchi M; Hewitt PE; Bennett P; Ward HJ; Will RG; Mackenzie JM; Sinka K
    Vox Sang; 2016 Nov; 111(4):325-332. PubMed ID: 27432362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.
    Luk C; Jones S; Thomas C; Fox NC; Mok TH; Mead S; Collinge J; Jackson GS
    JAMA Neurol; 2016 Dec; 73(12):1454-1460. PubMed ID: 27699415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
    Hamaguchi T; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Yamada M
    Neuropathology; 2009 Oct; 29(5):625-31. PubMed ID: 19659942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood transfusion and spread of variant Creutzfeldt-Jakob disease.
    Dietz K; Raddatz G; Wallis J; Müller N; Zerr I; Duerr HP; Lefèvre H; Seifried E; Löwer J
    Emerg Infect Dis; 2007 Jan; 13(1):89-96. PubMed ID: 17370520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.
    Hoots WK; Abrams C; Tankersleydagger D
    Transfus Med Rev; 2001 Apr; 15(2 Suppl 1):45-59. PubMed ID: 11441420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creutzfeldt-Jakob disease and blood transfusion safety.
    Seed CR; Hewitt PE; Dodd RY; Houston F; Cervenakova L
    Vox Sang; 2018 Apr; 113(3):220-231. PubMed ID: 29359329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives.
    Vamvakas EC
    J Clin Apher; 1999; 14(3):135-43. PubMed ID: 10540369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.
    Cooper JK; Andrews N; Ladhani K; Bujaki E; Minor PD
    Vox Sang; 2013 Oct; 105(3):196-204. PubMed ID: 23772892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of dose-response models of Creutzfeldt-Jakob disease infection in nonhuman primates for assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Huang Y; Gregori L; Anderson SA; Asher DM; Yang H
    J Virol; 2014 Dec; 88(23):13732-6. PubMed ID: 25231313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood transmission studies of prion infectivity in the squirrel monkey (Saimiri sciureus): the Baxter study.
    Ritchie DL; Gibson SV; Abee CR; Kreil TR; Ironside JW; Brown P
    Transfusion; 2016 Mar; 56(3):712-21. PubMed ID: 26594017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.